The U.S. Food and Drug Administration (FDA) announced on Monday the approval of the first generic version of a ...

GLP-1 receptor agonist weight loss drugs can negatively interact with eating disorder psychopathology and treatment in ...

This approval comes about seven months after the expiration ... creating a feeling of fullness and suppressing appetite, ...

Hopefully, the approval will help prevent ... Liraglutide, the generic for Victoza, is similar to semaglutide, the active ingredient in the popular weight-loss drug Ozempic.

Stay updated on the latest developments in the GLP-1 drug class, including a new generic entering the market, weight loss results, FDA decisions & cost issues.

Worried about mental health effects of ozempic? Here's what recent studies reveal about safety concerns and what you should discuss with your doctor ...

India's biopharma sector marked notable achievements, with approvals of key biosimilars and the launch of advanced CAR-T ...

Ozempic has gotten most of the name recognition associated with weight-loss drugs, it's not the only drug in this category ...